Skip to main content

Another Option: Clinical Trials

By LLS Staffer

clinical-trials-1.jpg

A blood cancer diagnosis typically leads one to an oncologist or hematologist, a cancer center and a conversation about available treatment options. One option that is not always presented is that of being part of a research study.

Clinical trials are carefully controlled studies of new or existing drugs, conducted by doctors. Researchers are trying to find ways to increase the effectiveness or decrease the side effects of treatment. A treatment that is proven safe and effective in a clinical trial often goes on to be approved by the U.S. Food and Drug Administration (FDA). This is how new lifesaving treatments are brought to market.

Through participation in a clinical trial, a patient can gain early access to an experimental therapy that may be more effective than standard treatments. Trials may also provide an alternative for someone unable to undergo a recommended procedure (such as a transplant). 

Related Blog Posts

Headshot - Beauchemin_Melissa Sq.jpg

The urgent challenge in blood cancer treatment: Ensuring every patient can access care

Dr. Gwen Nichols shares how Equity in Access research is revealing barriers to care and helping create paths forward for patients.

A scientist using a pipette with a microtiter plate and a petri dish

CAR T-cell therapy: A step-by-step guide for patients and families

A patient-friendly guide to CAR-T, including treatment steps, side effects, and recovery.

3D image of red blood cells with cancer cells

What is a bone marrow transplant? A patient-friendly guide to bone marrow transplantation

Learn what to expect before, during, and after a bone marrow transplant.

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.